These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 29240329)

  • 21. Intravesical Bacillus Calmette-Guerin for treating bladder cancer.
    Boyd LA
    Urol Nurs; 2003 Jun; 23(3):189-91, 199; quiz 192. PubMed ID: 12861735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mycotic aneurysm of the popliteal artery as a complication of intravesical BCG therapy for superficial bladder cancer. Case report and literature review.
    Witjes JA; Vriesema JL; Brinkman K; Bootsma G; Barentsz JO
    Urol Int; 2003; 71(4):430-2. PubMed ID: 14646447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epididymo-orchitis following intravesical bacillus Calmette-Guérin therapy.
    Menke JJ; Heins JR
    Ann Pharmacother; 2000 Apr; 34(4):479-82. PubMed ID: 10772435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BCG versus COVID-19: impact on urology.
    Desouky E
    World J Urol; 2021 Mar; 39(3):823-827. PubMed ID: 32417996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravesical therapy for bladder cancer.
    Kamat AM; Lamm DL
    Urology; 2000 Feb; 55(2):161-8. PubMed ID: 10688071
    [No Abstract]   [Full Text] [Related]  

  • 26. Intravesical therapy for superficial bladder cancer.
    Baselli EC; Greenberg RE
    Oncology (Williston Park); 2000 May; 14(5):719-29; discussion 729-31, 734, 737. PubMed ID: 10853462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnosis and management of adverse events occuring during BCG therapy for non-muscle invasive bladder cancer (NMIBC): review of the Cancer Committee of the French Association of Urology].
    Neuzillet Y; Rouprêt M; Wallerand H; Pignot G; Larré S; Irani J; Davin JL; Moreau JL; Soulié M; Pfister C;
    Prog Urol; 2012 Dec; 22(16):989-98. PubMed ID: 23178094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Imaging findings in BCGitis--Bacillus-Calmette-Guérin-Infektion (BCGitis) after intravesical BCG instillation therapy in urothelial carcinoma of the urinary bladder].
    Kaufmann S; Amend B; Kruck S; Gakis G; Bedke J; Horger M
    Rofo; 2015 Aug; 187(8):623-7. PubMed ID: 26218471
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prevention of Bacillus Calmette-Guérin immunotherapy complications].
    Colombel M; Picard A
    Prog Urol; 2008 May; 18 Suppl 5():S105-10. PubMed ID: 18585631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Endovesical immunotherapy: Calmette-Guérin bacillus].
    Chopin D; Saint F; Gattegno B
    Prog Urol; 2001 Nov; 11(5):1067-115. PubMed ID: 11769075
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of bacillus Calmette-Guerin refractory non-muscle invasive bladder cancer.
    Turker P; Turkeri L
    Arch Esp Urol; 2013 Nov; 66(9):833-40. PubMed ID: 24231293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is intravesical chemotherapy for superficial bladder cancer still justified?
    Okeke AA; Probert JL; Gillatt DA; Schwaibold H
    BJU Int; 2005 Oct; 96(6):763-7. PubMed ID: 16153195
    [No Abstract]   [Full Text] [Related]  

  • 33. Rationale for intravesical chemotherapy in the treatment and prophylaxis of superficial transitional cell carcinoma.
    Soloway MS; Jordan AM; Murphy WM
    Prog Clin Biol Res; 1989; 310():215-36. PubMed ID: 2505268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hazardous Drugs in the Urology Workplace: Focus on Intravesical Medications.
    Hensley D
    Urol Nurs; 2016; 36(4):183-9. PubMed ID: 29240329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complications of intravesical therapy for urothelial cancer of the bladder.
    Koya MP; Simon MA; Soloway MS
    J Urol; 2006 Jun; 175(6):2004-10. PubMed ID: 16697786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Haemophagocytic syndrome after intravesical bacille Calmette-Guérin instillation.
    Misra S; Gupta A; Symes A; Duncan J
    Scand J Urol; 2014 Jun; 48(3):328-30. PubMed ID: 24070063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nursing implications in the management of superficial bladder cancer.
    Games J
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):36-40. PubMed ID: 8727809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Calmette-Guerin bacillus disseminated infection after intravesical instillation].
    Borré S; Brustia D; Rosa F; Brondolo R; Rizzo G; Garavelli PL
    Recenti Prog Med; 2002 Apr; 93(4):247-8. PubMed ID: 11989131
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.